KEVIN MACKENZIE to Nuclear Receptor Coactivator 3
This is a "connection" page, showing publications KEVIN MACKENZIE has written about Nuclear Receptor Coactivator 3.
Connection Strength
0.048
-
Lead Compound Development of SRC-3 Inhibitors with Improved Pharmacokinetic Properties and Anticancer Efficacy. J Med Chem. 2024 04 11; 67(7):5333-5350.
Score: 0.048
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.